Robin S. B. Williams

7.7k total citations
99 papers, 3.6k citations indexed

About

Robin S. B. Williams is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Robin S. B. Williams has authored 99 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 23 papers in Physiology and 19 papers in Cell Biology. Recurrent topics in Robin S. B. Williams's work include Pharmacological Effects and Toxicity Studies (14 papers), Microtubule and mitosis dynamics (10 papers) and Diet and metabolism studies (10 papers). Robin S. B. Williams is often cited by papers focused on Pharmacological Effects and Toxicity Studies (14 papers), Microtubule and mitosis dynamics (10 papers) and Diet and metabolism studies (10 papers). Robin S. B. Williams collaborates with scholars based in United Kingdom, United States and Germany. Robin S. B. Williams's co-authors include Adrian J. Harwood, Matthew C. Walker, Anne W. Mudge, Lili Cheng, Pishan Chang, Sophie Williams, Knut H. Sørensen, Katrin Augustin, W.J. Ryves and Philip E. Chen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robin S. B. Williams

97 papers receiving 3.6k citations

Peers

Countries citing papers authored by Robin S. B. Williams

Since Specialization

Citations

This map shows the geographic impact of Robin S. B. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin S. B. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin S. B. Williams more than expected).

Fields of papers citing papers by Robin S. B. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin S. B. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin S. B. Williams. The network helps show where Robin S. B. Williams may publish in the future.

Co-authorship network of co-authors of Robin S. B. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Robin S. B. Williams. A scholar is included among the top collaborators of Robin S. B. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin S. B. Williams. Robin S. B. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional mechanism study of the allelochemical myrigalone A identifies a group of ultrapotent inhibitors of ethylene biosynthesis in plants 2024 ·Plant Communications ·(unknown), Kazumi Nakabayashi, Ana Espinosa‐Ruíz, (unknown), (unknown), Christopher R. L. Thompson, Katrin Hermann, David Alabadı́, Gerhard Leubner‐Metzger, Robin S. B. Williams	3
2	Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Stuart G. Snowden, (unknown), (unknown), (unknown), Jason King, Annette Müller‐Taubenberger, Robin S. B. Williams	1
3	Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis 2023 ·Cells ·(unknown), Joern R. Steinert, (unknown), (unknown), Robin S. B. Williams, Stuart G. Snowden, Hrvoje Augustin	3
4	Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome 2023 ·Annals of Clinical and Translational Neurology ·Naeimeh Tayebi, (unknown), Kevin McCall, (unknown), Kristin Engelstad, (unknown), Tychele N. Turner, (unknown), (unknown), Paul W. Hruz, Robin S. B. Williams, Darryl C. De Vivo, Vincent Petit, Gabe Haller, Christina A. Gurnett	5
5	Moving the Research Forward: The Best of British Biology Using the Tractable Model System Dictyostelium discoideum 2021 ·Cells ·Robin S. B. Williams, Jonathan R. Chubb, Robert H. Insall, Jason King, Catherine J. Pears, E. P. Thompson, Cornelis J. Weijer	7
6	Using Dictyostelium to Advance Our Understanding of the Role of Medium Chain Fatty Acids in Health and Disease 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Robin S. B. Williams	6
7	Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling 2020 ·Proceedings of the National Academy of Sciences ·(unknown), Stephanie Dooves, (unknown), (unknown), (unknown), Vivi M. Heine, Matthew C. Walker, Robin S. B. Williams	45
8	All You Need Is Fats—for Seizure Control: Using Amoeba to Advance Epilepsy Research 2018 ·Frontiers in Cellular Neuroscience ·(unknown), Matthew C. Walker, Robin S. B. Williams	14
9	Seizure Control by Derivatives of Medium Chain Fatty Acids Associated with the Ketogenic Diet Show Novel Branching-Point Structure for Enhanced Potency 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Pishan Chang, Alexandra M.E. Zuckermann, Sophie Williams, (unknown), Marifé Cano‐Jaimez, James P. McEvoy, John Spencer, Matthew C. Walker, Robin S. B. Williams	54
10	Epilepsy research methods update: Understanding the causes of epileptic seizures and identifying new treatments using non-mammalian model organisms 2014 ·Seizure ·Vincent T. Cunliffe, Richard A. Baines, Carlo NG Giachello, Wei‐Hsiang Lin, Alan Morgan, Markus Reuber, Claire Russell, Matthew C. Walker, Robin S. B. Williams	55
11	The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium 2011 ·Disease Models & Mechanisms ·Pishan Chang, (unknown), (unknown), (unknown), Oliver Hoeller, Jakob A. Shimshoni, Boris Yagen, Meir Bialer, Miriam L. Greenberg, Matthew C. Walker, Robin S. B. Williams	66
12	Dual mode of glucagon receptor internalization: role of PKCalpha, GRKs and beta-arrestins. 2011 ·Experimental Cell Research ·Lada Krilov, (unknown), Takuya Miyazaki, (unknown), Robin S. B. Williams	5
13	Inhibition of long‐term potentiation by valproic acid through modulation of cyclic AMP 2009 ·Epilepsia ·Pishan Chang, Kate Chandler, Robin S. B. Williams, Matthew C. Walker	16
14	Quantifying In Vivo Phosphoinositide Turnover in Chemotactically Competent Dictyostelium Cells 2009 ·Methods in molecular biology ·(unknown), Robin S. B. Williams	9
15	The neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum 2006 ·European Journal of Cell Biology ·Katrina Boeckeler, (unknown), Xuehua Xu, (unknown), Tian Jin, Robin S. B. Williams	38
16	Shaping technology, guiding policy: concepts, spaces and tools 2002 ·Edward Elgar eBooks ·Knut H. Sørensen, Robin S. B. Williams	119
17	Loss of the β-catenin homologue aardvark causes ectopic stalk formation in Dictyostelium 2002 ·Mechanisms of Development ·Juliet C. Coates, Mark J. Grimson, Robin S. B. Williams, (unknown), Richard L. Blanton, Adrian J. Harwood	28
18	The Politics of Constructionism 1998 ·Irving Velody, Robin S. B. Williams	50
19	The liver: biology and pathobiology 1988 ·Gut ·Robin S. B. Williams	112
20	New horizons in medical ethics. Research investigations in adults. 1973 ·BMJ ·(unknown), Robin S. B. Williams, L. J. Witts	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact